Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
Public ClinicalTrials.gov record NCT00005918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Safety and Antiviral Efficacy of Stavudine Extended Release Formulation as Compared to Stavudine Immediate Release Formulation, Each as Part of Potent Antiretroviral Combination Therapy
Study identification
- NCT ID
- NCT00005918
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 730 participants
Conditions and interventions
Conditions
Interventions
- Efavirenz Drug
- Lamivudine Drug
- Stavudine Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2000
- Primary completion
- Mar 31, 2002
- Completion
- Mar 31, 2002
- Last update posted
- May 3, 2011
2000 – 2002
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AIDS Healthcare Foundation | Los Angeles | California | 90027 | — |
| Whitman Walker Clinic | Washington D.C. | District of Columbia | 20009 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| Med Alternatives | Fort Lauderdale | Florida | 33308 | — |
| Hillsborough County Health Dept | Tampa | Florida | 33602 | — |
| The CORE Ctr | Chicago | Illinois | 60612 | — |
| Univ of Kansas School of Medicine | Wichita | Kansas | 672143124 | — |
| Univ of Louisville | Louisville | Kentucky | 40292 | — |
| CRI of New England | Brookline | Massachusetts | 02445 | — |
| CRI - Springfield | Springfield | Massachusetts | 01107 | — |
| No Nevada HOPES | Reno | Nevada | 89520 | — |
| Saint Luke's - Roosevelt Hosp Ctr | New York | New York | 10019 | — |
| Univ Hospital | Oklahoma City | Oklahoma | 73104 | — |
| Aesculapisu Medical Health Group | Dallas | Texas | 75204 | — |
| Univ of Texas Southwestern Med Ctr | Dallas | Texas | 75390 | — |
| Univ of Texas Med Branch | Galveston | Texas | 775550835 | — |
| Plaza Med Ctr | Houston | Texas | 77004 | — |
| Hampton Roads Med Specialists | Hampton | Virginia | 23666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00005918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2011 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00005918 live on ClinicalTrials.gov.